🇺🇸 FDA

Company profile · Sponsor

Camp4

Camp4 Therapeutics Corp

CAMP · NYSE pharma CAMBRIDGE, MA, USA
Pipeline
9
Drugs
0
Patents
4

Quick answer

Camp4 (CAMP) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker CAMP
Exchange NYSE
Company type pharma
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0001736730

Pipeline (9)

Search pipeline →

  1. Conventional sound generator (SG)

    Camp4

    Subjective Tinnitus

    phase 3 other completed

    1 trial

  2. IncobotulinumtoxinA (XEOMIN®)

    Camp4

    Chronic Migraine

    phase 3 small molecule active

    1 trial

  3. Ketamine Hydrochloride

    Camp4

    Suicide

    phase 3 small molecule terminated

    1 trial

  4. Placebo

    Camp4

    Asthma

    phase 3 small molecule completed

    1 trial

  5. Virtual Reality Exposure Therapy - Dynamic

    Camp4

    Post Traumatic Stress Disorder

    phase 3 other active

    1 trial

  6. Active smoked cannabis

    Camp4

    Cannabis Smoking

    phase 2 small molecule active

    1 trial

  7. Treatment as Usual

    Camp4

    Post-Traumatic Stress Disorder

    phase 2 other completed

    1 trial

  8. 15NH4Cl, Sodium Chloride for injection, [13C]Sodium Acetate, CMP-CPS-001

    Camp4

    Urea cycle disorders (UCD)

    phase 1 small molecule active

    1 trial

  9. CMP-CPS-001

    Camp4

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

Patents (4)

Search patents →

  1. US 12319916

    Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12145963

    Phenothiazine derivatives and uses thereof

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11542290

    Phenothiazine derivatives and uses thereof

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11266655

    Methods and compositions for treating urea cycle disorders

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Camp4?

Camp4 (CAMP) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does Camp4 sponsor?

We track 9 ClinicalTrials.gov-linked programs for Camp4, including Conventional sound generator (SG) and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Camp4 company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.